On the viral hypothesis of multiple sclerosis: Participation of varicella-zoster virus

Journal of the Neurological Sciences

Volumn 262, Issue 1-2, 2007, Pages 113-116

  Sotelo, Julio ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

Author keywords

DNA; Multiple sclerosis; Varicella zoster virus

Indexed keywords

ACICLOVIR; GANCICLOVIR; VIRUS DNA;

ARTICLE; DISEASE PREDISPOSITION; EVIDENCE BASED MEDICINE; GEOGRAPHIC DISTRIBUTION; HERPES ZOSTER; HUMAN; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RISK FACTOR; VARICELLA ZOSTER VIRUS; VIRUS PATHOGENESIS;

CHICKENPOX; GANGLIA; GENETIC PREDISPOSITION TO DISEASE; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; VACCINES; VIRAL LOAD;

EID: 34548596922     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.07.001     Document Type: Article

References (25)

1. Noseworthy J.H., Lucchinetti C., Rodriguez M., and Weishenker B.G. Multiple sclerosis. N Engl J Med 343 (2000) 938-952
2. Gilden D.H. Infectious causes of multiple sclerosis. Lancet Neurol 4 (2005) 195-202
3. Gonzalez O., and Sotelo J. Is the frequency of multiple sclerosis increasing in Mexico?. J Neurol Neurosurg Psychiatry 59 (1995) 528-530
4. Cordova J., Vargas S., and Sotelo J. Western and Asian features of multiple sclerosis in Mexican Mestizos. Clin Neurol Neurosurg 109 (2007) 146-151
5. Compston A., and Coles A. Multiple sclerosis. Lancet 359 (2002) 1221-1231
6. Tarrats R., Ordonez G., Rios C., and Sotelo J. Varicella, ephemeral breastfeeding and eczema as risk factors for multiple sclerosis in Mexicans. Acta Neurol Scand 105 (2002) 88-94
7. Murray J. Infection as a cause of multiple sclerosis. BMJ 325 (2002) 1128
8. Lenman J.A., and Peters T.J. Herpes zoster and multiple sclerosis. Br Med J 2 (1969) 218-220
9. Soldan S.S., Berti R., Salem N., Secchiero P., Flamand L., Calabresi P.A., et al. Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat Med 3 (1997) 1394-1397
10. Sundström P., Juto P., Wadell G., Hallmans G., Svenningsson A., Nystrom L., et al. An altered immune response to Epstein-Barr virus in multiple sclerosis. A prospective study. Neurology 62 (2004) 2277-2282
11. Simmons A. Herpesviruses and multiple sclerosis. Herpes 8 (2001) 60-63
12. Mameli G., Astone V., Arru G., Marconi S., Lovato L., Serra C., et al. Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MS-associated retrovirus/HERV-W endogenous retrovirus, but not human herpes virus 6. J Gen Virol 88 (2007) 264-274
13. Mirandola P., Stefan A., Brambilla E., Campadelli-Fiume G., and Grimaldi L.M. Absence of human herpesvirus 6 and 7 from spinal fluid and serum of multiple sclerosis patients. Neurology 53 (1999) 1367-1368
14. Ordonez G., Pineda B., Garcia-Navarrete R., and Sotelo J. Brief presence of varicella-zoster viral DNA in mononuclear cells during relapses of multiple sclerosis. Arch Neurol 61 (2004) 529-532
15. Perez-Cesari C., Saniger M.M., and Sotelo J. Frequent association of multiple sclerosis with varicella and zoster. Acta Neurol Scand 112 (2005) 417-419
16. Sotelo J, Ordonez G, Pineda B. Varicella-zoster virus at relapses of multiple sclerosis. J Neurol. (Published online, 31 March 2007 http://dx.doi.org/10.1007/s00415-006-0402-x).
17. Lungu O., Annunziato P.W., Gershon A., Staugaitis S.M., Josefson D., LaRussa P., et al. Reactivated and latent varicella-zoster virus in human dorsal root ganglia. Proc Natl Acad Sci U S A 92 (1995) 10980-10984
18. Gilden D.H., Kleinschmidt-Demasters B.K., LaGuardia J.J., Mahalingam R., and Cohrs R.J. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 342 (2000) 635-645
19. Gilden D.H., Lipton H.L., Wolf J.S., Akenbrandt W., Smith J.E., Mahalingam R., et al. Two patients with unusual forms of varicella-zoster virus vasculopathy. N Engl J Med 347 (2002) 1500-1503
20. Arvin A.M. Varicella-zoster virus. In: Knipe D.M., and Howley P.M. (Eds). Field's Virology. 4th ed. vol. II (2001), Lippincott Williams & Wilkins, Philadelphia, PA 2731-2767
21. Mainka C., Fuss B., Geiger H., Hofelmayr H., and Wolff M.H. Characterization of viremia at different stages of varicella-zoster virus infection. J Med Virol 56 (1998) 91-98
22. Arvin A.M. Varicella-zoster virus. In: Knipe D.M., and Howley P.M. (Eds). Field's Virology. 4th ed. vol. II (2001), Lippincott Williams & Wilkins, Philadelphia, PA 2731-2767
23. Hata A., Asanuma H., Rinki M., Sharp M., Wong R.M., Blume K., et al. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. N Engl J Med 347 (2002) 26-34
24. Chaves S.S., Gargiullo P., Zhang J.X., Civen R., Guris D., Mascola L., et al. Loss of vaccine-induced immunity to varicella over time. N Engl J Med 356 (2007) 1121-1129
25. Ross R., Nicolle L., and Cheang M. The varicella zoster virus: a pilot trial of a potential therapeutic agent in multiple sclerosis. J Clin Epidemiol 50 (1997) 63-68